Back
Akero Therapeutics Stock Price Chart
Sponsored
AKRO
Sponsored
Stock Market Legend Shares Biggest Prediction Ever:
Click Here to See
Sell
48
AKRO
Akero Therapeutics
Last Price:
25.24
Seasonality Move:
12.31%
7 Day Trial
ALL ACCESS PASS
$
7
NEW: AI Breakthrough to Send Economy Skyrocketing by $200 Trillion?
And with the one move I detail here, you can secure a share of this 10,000% boom.- The current trend is relatively stagnant and AKRO is experiencing slight buying pressure.
Akero Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.24 | Sell |
20-day SMA: | 27.54 | Sell |
50-day SMA: | 24.21 | Buy |
200-day SMA: | 31.66 | Sell |
8-day EMA: | 25.32 | Sell |
20-day EMA: | 26 | Sell |
50-day EMA: | 24.96 | Sell |
200-day EMA: | 28.74 | Sell |
Akero Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 43.35 | Sell |
Chaikin Money Flow: | 171453 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.88 - 29.44) | Sell |
Bollinger Bands (100): | (17.36 - 26.04) | Buy |
Akero Therapeutics Technical Analysis
Mar 14 | Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Akero Therapeutics Stock
Is Akero Therapeutics Stock a Buy?
- Akero Therapeutics share price is 24.48 while AKRO 8-day simple moving average is 25.24, which is a Sell signal.
- The stock price of AKRO is 24.48 while Akero Therapeutics 20-day SMA is 27.54, which makes it a Sell.
- Akero Therapeutics 50-day simple moving average is 24.21 while AKRO share price is 24.48, making it a Buy technically.
- AKRO stock price is 24.48 and Akero Therapeutics 200-day simple moving average is 31.66, creating a Sell signal.
AKRO Technical Analysis vs Fundamental Analysis
Sell
48
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy or a Sell?
-
Akero Therapeutics stock is rated a Sell
The current Akero Therapeutics [AKRO] share price is $24.48. The Score for AKRO is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Akero Therapeutics Stock Info
Market Cap:
1.69B
Price in USD:
24.48
Share Volume:
746.33K
Akero Therapeutics 52-Week Range
52-Week High:
58.38
52-Week Low:
11.25
Sell
48
Akero Therapeutics (AKRO)
is a Sell
Akero Therapeutics Share Price Forecast
-
What is the Akero Therapeutics stock price today?
The Akero Therapeutics stock price is 24.48 USD today. -
Will AKRO stock go up or go down?
Akero Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Akero Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akero Therapeutics is overvalued.
Is Akero Therapeutics Stock a Buy?
- Akero Therapeutics share price is 24.48 while AKRO 8-day exponential moving average is 25.32, which is a Sell signal.
- The stock price of AKRO is 24.48 while Akero Therapeutics 20-day EMA is 26.00, which makes it a Sell.
- Akero Therapeutics 50-day exponential moving average is 24.96 while AKRO share price is 24.48, making it a Sell technically.
- AKRO stock price is 24.48 and Akero Therapeutics 200-day simple moving average is 28.74, creating a Sell signal.
Fundamental Analysis of Akero Therapeutics
Is Akero Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.36 per share, a decrease next quarter of $0.16 per share, a decrease this year of $1.11 per share, and a decrease next year of $0.63 per share.
Technical Analysis of Akero Therapeutics
Should I short Akero Therapeutics stock?
- AKRO Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting Akero Therapeutics is a Sell
- Akero Therapeutics Relative Strength Index (RSI) is 43.35, which suggest Akero Therapeutics is oversold
- The Bollinger Bands (25) for Akero Therapeutics is (24.88 - 29.44), which suggest Akero Therapeutics is a Buy
- The Bollinger Bands (100) for Akero Therapeutics is (17.36 - 26.04), which suggest Akero Therapeutics is a Buy
* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.